Bio

Scott co-founded Iron Path Capital in 2021, co-leads the firm’s private equity execution and leads Iron Path’s “Full Immersion” program. Prior to founding Iron Path, he was an executive at NuSil Technology, a global leader in specialty materials for healthcare and aerospace applications. During his tenure as President of NuSil, Scott led the team that diversified the company into new market segments including electronics, personal care and drug-delivery and grew internationally by expanding in Europe and building a business in Asia. Scott currently serves on the boards of Boulder Scientific Company, Emergence Health and Versant Diagnostics. He previously was an executive advisor to New Mountain Capital and a member of Quad-C’s executive advisory board. He has sourced and executed several private transactions in the specialty industrials sector, including New Mountain Capital’s acquisition of Gelest in 2017 and Quad-C’s acquisition of Boulder Scientific Company in 2019. Prior to joining NuSil, Scott was an investment professional at Quad-C and Apax Partners, where he evaluated and executed private equity investments in various industries. He also previously held investment banking roles at Merrill Lynch in M&A and Bank of America in Leveraged Finance. Scott holds a B.S. degree in Finance and Accounting from Ithaca College.